Literature DB >> 3081111

Treatment of severe rheumatoid arthritis.

V Wright.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081111      PMCID: PMC1339418          DOI: 10.1136/bmj.292.6518.431

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  22 in total

1.  Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.

Authors:  R GUBNER; S AUGUST; V GINSBERG
Journal:  Am J Med Sci       Date:  1951-02       Impact factor: 2.378

2.  Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage.

Authors:  H E Paulus; H I Machleder; S Levine; D T Yu; N S MacDonald
Journal:  Arthritis Rheum       Date:  1977 Jul-Aug

3.  Risk of cancer in renal-transplant recipients.

Authors:  R Hoover; J F Fraumeni
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

4.  The effect of thoracic duct drainage on lymphocyte dynamics and clinical symptoms in patients with rheumatoid arthritis.

Authors:  T Ueo; S Tanaka; Y Tominaga; H Ogawa; T Sakurami
Journal:  Arthritis Rheum       Date:  1979-12

5.  Cyclophosphamide therapy for rheumatoid arthritis.

Authors:  C J Smyth; B A Bartholomew; D M Mills; J C Steigerwald; S J Strong; S Recart
Journal:  Arch Intern Med       Date:  1975-06

Review 6.  Disease-modifying drugs for progressive rheumatoid arthritis.

Authors:  T W Bunch; J D O'Duffy
Journal:  Mayo Clin Proc       Date:  1980-03       Impact factor: 7.616

7.  Lymphocyte depletion by continuous flow cell centrifugation in rheumatoid arthritis: clinical effects.

Authors:  J Karsh; D G Wright; J H Klippel; J L Decker; A B Deisseroth; M W Flye
Journal:  Arthritis Rheum       Date:  1979-10

8.  Controlled trial of cyclophosphamide in rheumatoid arthritis.

Authors:  A S Townes; J M Sowa; L E Shulman
Journal:  Arthritis Rheum       Date:  1976 May-Jun

9.  Functional effects of thymopoietin32-36 (TP5) on cytotoxic lymphocyte precursor units (CLP-U). I. Enhancement of splenic CLP-U in vitro and in vivo after suboptimal antigenic stimulation.

Authors:  C Y Lau; G Goldstein
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

10.  A combined clinical and immunological assessment of four cyclophosphamide regimes in rheumatoid arthritis.

Authors:  N D Hall; H A Bird; E F Ring; P A Bacon
Journal:  Agents Actions       Date:  1979-04
View more
  4 in total

1.  Anti-inflammatory effect of Pinus sibirica oil extract in animal models.

Authors:  Alexander N Shikov; Olga N Pozharitskaya; Valery G Makarov; Marina N Makarova
Journal:  J Nat Med       Date:  2008-05-02       Impact factor: 2.343

Review 2.  Sulphasalazine in arthritis--an old drug rediscovered.

Authors:  A J Taggart
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

3.  Clinical efficacy of Rasona Pinda in the management of Amavata (rheumatoid arthritis).

Authors:  Jai Prakash Singh; Meera Antiwal; Amit Vaibhav; J S Tripathi; S K Tiwari
Journal:  Ayu       Date:  2010-07

4.  Clinical efficacy of Shiva Guggulu and Simhanada Guggulu in Amavata (Rheumatoid Arthritis).

Authors:  Shweta A Pandey; Nayan P Joshi; Dilip M Pandya
Journal:  Ayu       Date:  2012-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.